Simple and validated UV-spectroscopic method for estimation of moxifloxacin.HCL in bulk and formulation

Journal of Global Pharma Technology

Volumn 2, Issue 6, 2010, Pages 21-27

  Misra, M ^a   Misra, A K ^b   Zope, P ^c   Panpalia, G M ^d   Dorle, A K ^e  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER AHMEDABAD   (India)

^b Cadila Pharmaceuticals Limited   (India)

^c Novartis Global Quality Analytical Services   (United Kingdom)

^d BIRLA INSTITUTE OF TECHNOLOGY   (India)

^e RTM NAGPUR UNIVERSITY   (India)

Author keywords

Fluoroquinolone; Moxifloxacin HCl; UV spectroscopy

Indexed keywords

CALCIUM PHOSPHATE DIBASIC; HYDROCHLORIC ACID; LACTOSE; MAGNESIUM STEARATE; MOXIFLOXACIN; STARCH; TALC;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG QUALITY; DRUG STRUCTURE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; TABLET; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 79952645291     PISSN: None     EISSN: 09758542     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Andriole, V.T. The quinolones: Prospects. In The Quinolones, 3rd ed.; Andriole, V.T. eds.; London: Academic Press; 2000. p. 487.
2. Keutz E.V., Schluter G. Preclinical safety evaluation of moxifloxacin, a novel fluroquinolone. J. Antimicrob Chemother. 1999; Suppl. B. 43: 91-100.
3. Kumar R.Y., Raju P.V.V.N.K.V., Kumar R.R, Eswaraiah S, Mukkanti K, Suryanarayana M.V, Reddy S.M. Structural identification and characterization of impurities in moxifloxacin. J. Pharm. Biomed. Anal. 2004; 34: 1125-1129.
4. USP DI.2001. Vol.I, 21st edition. New York, NY: Micromedex,.p.1528-1543.
5. Miyazaki E., Miyazaki M., Chen J.M., Chaisson R.E., Bishai W.R. Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob. Agents Chemother. 1999; 43 (1): 85-89.
6. Ulu TS. High performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma. J. Pharm. Biomed. Anal. 2007;.43: 320-324..
7. Djurdjevic A.L., Stankov M.J., Djurdjevic P. Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. J. Chromatgr. B. 2006; 844: 104-111.
8. Gonzalez J.A.O., Mochon M.C., Barragan F.J., Rosa de L. Simultaneous determination of cefepime, and the quinolones garenoxacin, moxifloxacin and levofloxacin in human urine by HPLC-UV. Microchim. Acta. 2005; 151: 39-45.
9. Ba B.B., Etienne R., Ducint D., Quentin C., Saux M.C. Determination of moxifloxacin in growth media by high performance liquid chromatography. J. Chromatgr. B. 2001; 754: 107-112.
10. Lemoine T., Breilh D., Ducint D., Dubrez J., Jougon J., Velly J.F., Saux, M.C. Determination of moxifloxacin (Bay12-8039) in plasma and lung tissue by high performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric catridge. J. Chromatgr. B. 2007; 42: 247-254.
11. Radhakrishna T., Rao S.D., Vyas K., Reddy G.O. Enantiomeric separation of a moxifloxacin intermediate by chiral liquid chromatography using cellulose based stationary phases. J. Pharm. Biomed. Anal. 2000; 22: 691-697.
12. Tobin C.M., Sunderland J., White L.O., MacGowan A.P., Reeves D.S. An isocratic high performance liquid chromatography (HPLC) assay for moxifloxacin, a new 8-methoxyquinolone. J. Antimicrob. Chemother 1998; 42: 278-279.
13. Stass H., Dalhoff A. Determination of (Bay12-8039), a new 8-methoxyquinolone, in human body fluids by high performance liquid chromatography with fluorescence detection using on-column focusing. J. Chromatgr. B. 1997; 702: 163-174.
14. Cruz L.A., Hall R. Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis. J. Pharm. Biomed. Anal. 2005; 38: 8-13.
15. Moller J.G., Stass H., Heining R., Blaschke, G. Capillary electrophoresis with laser induced fluorescence: a routine method to determine moxifloxacin in human body fluids in very small sample volumes. J. Chromatgr. B. 1998; 716: 325-334.
16. Karthick V., Bartlett M.G., Stewart J.T. Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 2002; 30: 961-968.
17. Guerra F.L.B, Paim C.S., Steppe M., Schapoval E.E.S. Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets. JAOAC. 2005; 88: 1086-1092.
18. Nguyen H.A., Grellet J., Ba B.B., Quentin C., Saux M.C. Simultaneous determination of levofloxacin, gatifloxacin, and moxifloxacin in serum by liquid chromatography with column switching. J. Chromatgr. B. 2004; 810: 77-83.
19. Erk N. Voltametric behavior and determination of moxifloxacin in pharmaceutical products and human plasma. Anal. Bioanal. Chem. 2004; 378: 1351.
20. The European agency for the evaluation of medical/products. ICH Topic Q2B note for guidance on validation of analytical procedures: methodology GPMP/ICH/281/195, 1996.